What is Metformin-pioglitazone?

Category: Prescription Drugs

Most popular types: Actoplus Met Glizone M Triglynase


Metformin and pioglitazone is a combination of two oral diabetes medicines that help control blood sugar levels. It is for people with type 2 diabetes who do not use daily insulin injections.

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations

Commonly reported side effects and conditions associated with Metformin-pioglitazone

Side effect Patients
Fatigue 2
Diarrhea 1
Irregular heartbeat (cardiac arrhythmia) 1


Based on patients currently taking Metformin-pioglitazone

Dosage Patients
500-15 mg daily 1
500-15 mg three times daily 1

Why patients stopped taking Metformin-pioglitazone

Multiple reasons could be selected

Reason Patients
Change in health plan coverage 1
Doctor's advice 1
Side effects too severe 1
See all 3 patients who've stopped taking Metformin-pioglitazone


Currently taking Metformin-pioglitazone

Duration Patients
1 - 2 years 1
2 - 5 years 2

Stopped taking Metformin-pioglitazone

Duration Patients
2 - 5 years 2
10 years or more 1
Adherence Evaluations
Always 3
Usually 0
Sometimes 2
Never taken as prescribed 0
Burden Evaluations
Very hard to take 0
Somewhat hard to take 2
A little hard to take 1
Not at all hard to take 2
Cost per month
Cost per month Evaluations
$200+ 1
$100-199 0
$50-99 1
$25-49 0
< $25 1
Not specified 2

What people switch to and from

Patients started taking Metformin-pioglitazone after stopping:

Treatment Patients
Liraglutide (Victoza) 1

Patients stopped taking Metformin-pioglitazone and switched to:

Treatment Patients
Glimepiride (Amaryl) 1
Metformin-vildagliptin (Galvus Met) 1
Last updated:
There are no evaluations for Metformin-pioglitazone.